V.3 Is there life after tamoxifen? New anti-oestrogens

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  O'Regan, R ^a   Cisneros, A ^a   Jordan, V C ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FULVESTRANT; TAMOXIFEN; TOREMIFENE;

BREAST CANCER; CLINICAL TRIAL; CONFERENCE PAPER; ENDOMETRIUM CANCER; HUMAN; INCIDENCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031669446     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00117-8     Document Type: Conference Paper

References (2)

1. Assikis VJ, Neven P, Jordan VC, Vergote I. A realistic clinical perspective of tamoxifen and endometrial carcinogenesis. Eur J Cancer 1996, 32A, 1464-1476.
2. Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC. Contrasting actions of tamoxifen on endometrial and breast cancer growth in the athymic mouse. Cancer Res 1988, 48, 812-815.